Free Trial

Mackenzie Financial Corp Acquires Shares of 21,023 Pediatrix Medical Group, Inc. (NYSE:MD)

Pediatrix Medical Group logo with Medical background

Mackenzie Financial Corp bought a new stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 21,023 shares of the company's stock, valued at approximately $276,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Vanguard Group Inc. raised its holdings in shares of Pediatrix Medical Group by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 10,812,611 shares of the company's stock valued at $141,861,000 after purchasing an additional 113,976 shares in the last quarter. Boston Partners increased its holdings in Pediatrix Medical Group by 25.2% in the fourth quarter. Boston Partners now owns 1,956,353 shares of the company's stock valued at $25,922,000 after buying an additional 393,600 shares during the last quarter. Geode Capital Management LLC raised its stake in Pediatrix Medical Group by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company's stock valued at $25,562,000 after buying an additional 11,045 shares in the last quarter. American Century Companies Inc. lifted its holdings in Pediatrix Medical Group by 628.2% during the 4th quarter. American Century Companies Inc. now owns 1,739,323 shares of the company's stock worth $22,820,000 after buying an additional 1,500,485 shares during the last quarter. Finally, Northern Trust Corp lifted its holdings in Pediatrix Medical Group by 18.0% during the 4th quarter. Northern Trust Corp now owns 966,347 shares of the company's stock worth $12,678,000 after buying an additional 147,522 shares during the last quarter. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Performance

MD traded up $0.19 during trading on Friday, hitting $14.11. 771,894 shares of the stock were exchanged, compared to its average volume of 835,647. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67. The stock has a fifty day moving average price of $13.66 and a two-hundred day moving average price of $14.02. The firm has a market capitalization of $1.21 billion, a P/E ratio of -11.76, a PEG ratio of 1.74 and a beta of 1.27.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.08. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The business had revenue of $458.36 million for the quarter, compared to analyst estimates of $451.44 million. During the same period last year, the firm posted $0.20 earnings per share. The company's revenue for the quarter was down 7.4% compared to the same quarter last year. As a group, sell-side analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analysts Set New Price Targets

MD has been the topic of several research analyst reports. Macquarie raised their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a research report on Thursday, May 8th. Truist Financial cut their price objective on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Finally, UBS Group reduced their price objective on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research report on Monday, May 12th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $16.67.

Get Our Latest Stock Analysis on Pediatrix Medical Group

Pediatrix Medical Group Company Profile

(Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Featured Stories

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Should You Invest $1,000 in Pediatrix Medical Group Right Now?

Before you consider Pediatrix Medical Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.

While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines